Vitiligo: A comprehensive overview: Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up

Journal of the American Academy of Dermatology

Volumn 65, Issue 3, 2011, Pages 473-491

  Alikhan, Ali ^a   Felsten, Lesley M ^a   Daly, Meaghan ^b   Petronic Rosic, Vesna ^c  

^a MACNEAL HOSPITAL   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

autoimmune; depigmentation; depigmented; hypopigmentation; hypopigmented; leukoderma; macule; melanocyte; melanosome; vitiligo

Indexed keywords

ANTINUCLEAR ANTIBODY; HLA A2 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; NACHT LEUCINE RICH REPEAT PROTEIN 1; PHENOL DERIVATIVE; PROTEIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX9; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ALOPECIA AREATA; AMELANOTIC MELANOMA; AMELANOTIC NEVUS; ANTIBODY TITER; ATOPIC DERMATITIS; AUTOCYTOTOXIC HYPOTHESIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOSOMAL DOMINANT DISORDER; BIOCHEMISTRY; BLOOD CELL COUNT; CD4 CD8 RATIO; CELL SURVIVAL; CELLULAR IMMUNITY; CHEMICAL LEUKODERMA; CHLOASMA; CLINICAL ASSESSMENT; CONFOCAL MICROSCOPY; DEPIGMENTATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG INDUCED DEPIGMENTATION; EMOTIONAL STRESS; ERYTHEMA STREPTOGENES; ETHNIC GROUP; EUROPE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HALO NEVUS; HAPLOTYPE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; HYPOMELANOSIS OF ITO; HYPOTHESIS; IDIOPATHIC GUTTATE HYPOMELANOSIS; IMMUNOHISTOCHEMISTRY; LEISHMANIASIS; LEPROSY; LICHEN SCLEROSUS ET ATROPHICUS; LICHEN STRIATUSE LIKE LEUKODERMA; MELANOCYTE; MELANOCYTORRHAGY HYPOTHESIS; MELANOMA ASSOCIATED LEUKODERMA; MELAS SYNDROME; MENTAL STRESS; MYCOSIS FUNGOIDES; NEUROHUMORAL HYPOTHESIS; NEVUS ANEMICUS; NUMMULAR DERMATITIS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL VITILIGO; ONCHOCERCIASIS; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; PHOTOTHERAPY INDUCED HYPOPIGMENTATION; PIEBALDISM; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MACULAR HYPOMELANOSIS; PSORIASIS; QUALITY OF LIFE; RADIOTHERAPY INDUCED HYPOPIGMENTATION; REVIEW; RHEUMATOID ARTHRITIS; SCAR; SCHMIDT SYNDROME; SKIN ALLERGY; SKIN DISEASE; SKIN EXAMINATION; SKIN INJURY; SUNBURN; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DYSGENESIS; TINEA VERSICOLOR; TOPICAL INDUCED DEPIGMENTATION; TREATMENT RESPONSE; TREPONEMATOSIS; TUBEROUS SCLEROSIS; ULTRAVIOLET IRRADIATION; UNITED STATES; VITILIGO; VOGT KOYANAGI SYNDROME; WAARDENBURG SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; QUALITY OF LIFE; VITILIGO;

EID: 80051738735     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.11.061     Document Type: Review

References (218)

1. K.P. Kyriakis, I. Palamaras, E. Tsele, C. Michailides, and S. Terzoudi Case detection rates of vitiligo by gender and age Int J Dermatol 48 2009 328 329
2. Z. Zhang, S.X. Xu, F.Y. Zhang, X.Y. Yin, S. Yang, and F.L. Xiao The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients Arch Dermatol Res 301 2009 167 173
3. J.R. Porter, and A.H. Beuf Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients J Health Soc Behav 32 1991 192 204
4. A. Nanda, S. Kaur, O.N. Bhakoo, and K. Dhall Survey of cutaneous lesions in Indian newborns Pediatr Dermatol 6 1989 39 42 (Pubitemid 19098549)
5. E. Tamer, M.N. Ilhan, M. Polat, N. Lenk, and N. Alli Prevalence of skin diseases among pediatric patients in Turkey J Dermatol 35 2008 413 418 (Pubitemid 351977688)
6. A. Taieb, and M. Picardo Clinical practice. Vitiligo N Engl J Med 360 2009 160 169
7. A. Taieb, and M. Picardo The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force Pigment Cell Res 20 2007 27 35 (Pubitemid 46090162)
8. D.J. Gawkrodger, A.D. Ormerod, L. Shaw, I. Mauri-Sole, M.E. Whitton, and M.J. Watts Guideline for the diagnosis and management of vitiligo Br J Dermatol 159 2008 1051 1076
9. J. Castanet, and J.P. Ortonne Pathophysiology of vitiligo Clin Dermatol 15 1997 845 851 (Pubitemid 27521611)
10. A. Firooz, N. Bouzari, N. Fallah, B. Ghazisaidi, M.R. Firoozabadi, and Y. Dowlati What patients with vitiligo believe about their condition Int J Dermatol 43 2004 811 814 (Pubitemid 39529939)
11. T. Lu, T. Gao, A. Wang, Y. Jin, Q. Li, and C. Li Vitiligo prevalence study in Shaanxi Province, China Int J Dermatol 46 2007 47 51 (Pubitemid 46029724)
12. J. Howitz, H. Brodthagen, M. Schwartz, and K. Thomsen Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark Arch Dermatol 113 1977 47 52 (Pubitemid 8020128)
13. S.K. Das, P.P. Majumder, R. Chakraborty, T.K. Majumdar, and B. Haldar Studies on vitiligo. I. Epidemiological profile in Calcutta, India Genet Epidemiol 2 1985 71 78 (Pubitemid 15101651)
14. M. Dwivedi, N.C. Laddha, E.M. Shajil, B.J. Shah, and R. Begum The ACE gene I/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population Pigment Cell Melanoma Res 21 2008 407 408 (Pubitemid 351678083)
15. S. Dogra, D. Parsad, S. Handa, and A.J. Kanwar Late onset vitiligo: a study of 182 patients Int J Dermatol 44 2005 193 196 (Pubitemid 40425661)
16. A.N. Onunu, and E.P. Kubeyinje Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria Int J Dermatol 42 2003 800 802 (Pubitemid 37304044)
17. R.M. Halder, and S.J. Taliaferro Vitiligo K. Wolff, L. Goldsmith, S. Katz, B. Gilchrest, A. Paller, D. Lefell, Fitzpatrick's dermatology in general medicine 2008 McGraw-Hill New York 72
18. A. Alkhateeb, P.R. Fain, A. Thody, D.C. Bennett, and R.A. Spritz Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families Pigment Cell Res 16 2003 208 214 (Pubitemid 36597056)
19. V.N. Sehgal, V.L. Rege, F. Mascarenhas, and V.N. Kharangate Clinical pattern of vitiligo amongst Indians J Dermatol 3 1976 49 53
20. A. Alzolibani Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia Acta Dermatovenerol Alp Panonica Adriat 18 2009 119 125
21. S. Handa, and I. Kaur Vitiligo: clinical findings in 1436 patients J Dermatol 26 1999 653 657 (Pubitemid 29510347)
22. J.S. Jarallah, O.A. Al-Sheikh, M. El-Shabrawy, and M.A. Al-Wakeel Vitiligo: epidemiology and clinical pattern at King Khalid University Hospital Ann Saudi Med 13 1993 332 334 (Pubitemid 23284420)
23. A.A. Al Robaee Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia Saudi Med J 28 2007 1414 1417
24. S. Handa, and S. Dogra Epidemiology of childhood vitiligo: a study of 625 patients from north India Pediatr Dermatol 20 2003 207 210 (Pubitemid 36736777)
25. T.J. Jaisankar, M.C. Baruah, and B.R. Garg Vitiligo in children Int J Dermatol 31 1992 621 623
26. M. Dolatshahi, P. Ghazi, V. Feizy, and M.R. Hemami Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran Indian J Dermatol Venereol Leprol 74 2008 700
27. L. Borimnejad, Z. Parsa Yekta, A. Nikbakht-Nasrabadi, and A. Firooz Quality of life with vitiligo: comparison of male and female Muslim patients in Iran Gend Med 3 2006 124 130 (Pubitemid 44057820)
28. M. Augustin, A.I. Gajur, C. Reich, S.J. Rustenbach, and I. Schaefer Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire Dermatology 217 2008 101 106
29. P. Kostopoulou, T. Jouary, B. Quintard, K. Ezzedine, S. Marques, and S. Boutchnei Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre Br J Dermatol 161 2009 128 133
30. M.A. Radtke, I. Schafer, A. Gajur, A. Langenbruch, and M. Augustin Willingness-to-pay and quality of life in patients with vitiligo Br J Dermatol 161 2009 134 139
31. A. Mechri, M. Amri, A.A. Douarika, B.H. Ali Hichem, B. Zouari, and J. Zili Psychiatric morbidity and quality of life in Vitiligo: a case controlled study [in French] Tunis Med 84 2006 632 635 (Pubitemid 44885445)
32. K. Ongenae, N. Van Geel, S. De Schepper, and J.M. Naeyaert Effect of vitiligo on self-reported health-related quality of life Br J Dermatol 152 2005 1165 1172 (Pubitemid 40933413)
33. S. Aghaei, M. Sodaifi, P. Jafari, N. Mazharinia, and A.Y. Finlay DLQI scores in vitiligo: reliability and validity of the Persian version BMC Dermatol 4 2004 8
34. G. Kent, and M. al-Abadie Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers Clin Exp Dermatol 21 1996 330 333 (Pubitemid 27075314)
35. D. Parsad, R. Pandhi, S. Dogra, A.J. Kanwar, and B. Kumar Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome Br J Dermatol 148 2003 373 374 (Pubitemid 36278994)
36. M.W. Linthorst Homan, P.I. Spuls, J. de Korte, J.D. Bos, M.A. Sprangers, and J.P. van der Veen The burden of vitiligo: patient characteristics associated with quality of life J Am Acad Dermatol 61 2009 411 420
37. Y. Kim do, J.W. Lee, S.H. Whang, Y.K. Park, S.K. Hann, and Y.J. Shin Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles J Dermatol 36 2009 317 322
38. H. Belhadjali, M. Amri, A. Mecheri, A. Doarika, H. Khorchani, and M. Youssef Vitiligo and quality of life: a case-control study [in French] Ann Dermatol Venereol 134 2007 233 236 (Pubitemid 46524241)
39. G. Schmid-Ott, H.W. Kunsebeck, E. Jecht, R. Shimshoni, I. Lazaroff, and S. Schallmayer Stigmatization experience, coping and sense of coherence in vitiligo patients J Eur Acad Dermatol Venereol 21 2007 456 461 (Pubitemid 46454896)
40. M. Sukan, and F. Maner The problems in sexual functions of vitiligo and chronic urticaria patients J Sex Marital Ther 33 2007 55 64 (Pubitemid 44949972)
41. S.K. Mattoo, S. Handa, I. Kaur, N. Gupta, and R. Malhotra Psychiatric morbidity in vitiligo: prevalence and correlates in India J Eur Acad Dermatol Venereol 16 2002 573 578 (Pubitemid 35385745)
42. S.K. Mattoo, S. Handa, I. Kaur, N. Gupta, and R. Malhotra Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India J Dermatol 28 2001 424 432 (Pubitemid 32862058)
43. G. Kent, and M. Al'sAbadie Psychologic effects of vitiligo: a critical incident analysis J Am Acad Dermatol 35 1996 895 898 (Pubitemid 26422112)
44. N. Sharma, R.V. Koranne, and R.K. Singh Psychiatric morbidity in psoriasis and vitiligo: a comparative study J Dermatol 28 2001 419 423 (Pubitemid 32862057)
45. S. Choi, D.Y. Kim, S.H. Whang, J.H. Lee, S.K. Hann, and Y.J. Shin Quality of life and psychological adaptation of Korean adolescents with vitiligo J Eur Acad Dermatol Venereol 24 2010 524 529
46. J.P. Ortonne Vitiligo and other disorders of hypopigmentation J. Bolognia, J. Jorizzo, R. Rapini, Dermatology 2008 Mosby Elsevier Philadelphia 928
47. P.N. Behl, and R.K. Bhatia 400 cases of vitiligo. A clinico-therapeutic analysis Indian J Dermatol 17 1972 51 56
48. S.S. Bleehen, and A.V. Anstey Disorders of skin colour T. Burns, S. Breathnach, N. Cox, C. Griffiths, Rook's textbook of dermatology 2004 Blackwell Malden, MA 39
49. T. El-Din Anbar, A.T. Abdel-Rahman, M.A. El-Khayyat, and A.E. El-Azhary Vitiligo on anterior aspect of neck in Muslim females: case series Int J Dermatol 47 2008 178 179
50. M. Ardigo, I. Malizewsky, M.L. Dell'sanna, E. Berardesca, and M. Picardo Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy J Eur Acad Dermatol Venereol 21 2007 1344 1350 (Pubitemid 350020141)
51. C.P. Mason, and D.J. Gawkrodger Vitiligo presentation in adults Clin Exp Dermatol 30 2005 344 345 (Pubitemid 40835323)
52. S.B. Verma Vitiligo precipitated by striae: a little known entity J Eur Acad Dermatol Venereol 23 2009 357 358
53. N.R. Mehta, K.C. Shah, C. Theodore, V.P. Vyas, and A.B. Patel Epidemiological study of vitiligo in Surat area, South Gujarat Indian J Med Res 61 1973 145 154
54. L. Manolache, and V. Benea Stress in patients with alopecia areata and vitiligo J Eur Acad Dermatol Venereol 21 2007 921 928 (Pubitemid 47103722)
55. V. Barisić-Drusko, and I. Rucević Trigger factors in childhood psoriasis and vitiligo Coll Antropol 28 2004 277 285 (Pubitemid 38901292)
56. S.K. Hann, W.H. Chun, and Y.K. Park Clinical characteristics of progressive vitiligo Int J Dermatol 36 1997 353 355 (Pubitemid 27278499)
57. J. Mazereeuw-Hautier, S. Bezio, E. Mahe, C. Bodemer, C. Eschard, and V. Viseux Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study J Am Acad Dermatol 62 2010 945 949
58. W.H. Chun, and S.K. Hann The progression of nonsegmental vitiligo: clinical analysis of 318 patients Int J Dermatol 36 1997 908 910 (Pubitemid 28053891)
59. E.M. Shajil, S. Chatterjee, D. Agrawal, T. Bagchi, and R. Begum Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes Indian J Exp Biol 44 2006 526 539 (Pubitemid 44049404)
60. J.J. Nordlund, and A.B. Lerner Vitiligo. It is important Arch Dermatol 118 1982 5 8 (Pubitemid 12207195)
61. O. Arycan, K. Koc, and L. Ersoy Clinical characteristics in 113 Turkish vitiligo patients Acta Dermatovenerol Alp Panonica Adriat 17 2008 129 132
62. S.K. Hann, and H.J. Lee Segmental vitiligo: clinical findings in 208 patients J Am Acad Dermatol 35 1996 671 674 (Pubitemid 26389462)
63. M.I. Barona, A. Arrunategui, R. Falabella, and A. Alzate An epidemiologic case-control study in a population with vitiligo J Am Acad Dermatol 33 1995 621 625
64. M.W. Linthorst Homan, M.A. Sprangers, J. de Korte, J.D. Bos, and J.P. van der Veen Characteristics of patients with universal vitiligo and health-related quality of life Arch Dermatol 144 2008 1062 1064
65. S.K. Hann, Y.S. Kim, J.H. Yoo, and Y.S. Chun Clinical and histopathologic characteristics of trichrome vitiligo J Am Acad Dermatol 42 2000 589 596 (Pubitemid 30479881)
66. L. Chandrashekar Dermatoscopy of blue vitiligo Clin Exp Dermatol 34 2009 e125 e126
67. S. Ghosh, and S. Mukhopadhyay Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country Br J Dermatol 160 2009 40 47
68. A.O. George Vitiligo in Ibadan, Nigeria. Incidence, presentation, and problems in management Int J Dermatol 28 1989 385 387 (Pubitemid 19217239)
69. C.J. Stevenson Occupational vitiligo: clinical and epidemiological aspects Br J Dermatol 105 suppl 21 1981 51 56 (Pubitemid 12225670)
70. G. Mancuso, M. Reggiani, and R.M. Berdondini Occupational dermatitis in shoemakers Contact Derm 34 1996 17 22 (Pubitemid 26019822)
71. G. Nagy, and I. Korom Late skin symptoms of arsenic poisoning in the arsenic endemy in Bugac-Alsomonostor [in German] Z Hautkr 58 1983 961 964 (Pubitemid 13036384)
72. Y.C. Kim, Y.J. Kim, H.Y. Kang, S. Sohn, and E.S. Lee Histopathologic features in vitiligo Am J Dermatopathol 30 2008 112 116 (Pubitemid 351441981)
73. O.E. Pagovich, J.I. Silverberg, E. Freilich, and N.B. Silverberg Thyroid abnormalities in pediatric patients with vitiligo in New York City Cutis 81 2008 463 466
74. P. Iacovelli, J.L. Sinagra, A.P. Vidolin, S. Marenda, B. Capitanio, and G. Leone Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo Dermatology 210 2005 26 30 (Pubitemid 39656715)
75. T. Kakourou, C. Kanaka-Gantenbein, A. Papadopoulou, E. Kaloumenou, and G.P. Chrousos Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo J Am Acad Dermatol 53 2005 220 223 (Pubitemid 40979575)
76. M. Dittmar, and G.J. Kahaly Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up J Clin Endocrinol Metab 88 2003 2983 2992 (Pubitemid 36877459)
77. R. Frati, C. Frati, P.P. Sassano, and A. Antonaci Vitiligo, autoimmune thyroiditis: a rare thyroid cancer arising with bone metastates on maxillofacial area J Exp Clin Cancer Res 18 1999 85 87 (Pubitemid 29232078)
78. S. Artantas, U. Gul, A. Kilic, and S. Guler Skin findings in thyroid diseases Eur J Intern Med 20 2009 158 161
79. Y.K. Shong, and J.A. Kim Vitiligo in autoimmune thyroid disease Thyroidology 3 1991 89 91
80. S.K. Hann, S. Im, H.I. Kim, H.S. Kim, Y.J. Lee, and Y.K. Park Increased incidence of antismooth muscle antibody in Korean vitiligo patients J Dermatol 20 1993 679 683 (Pubitemid 24025203)
81. F.C. Powell, and C.H. Dicken Psoriasis and vitiligo Acta Derm Venereol 63 1983 246 249 (Pubitemid 13094651)
82. L. Chandrashekar Red in white sea sign J Eur Acad Dermatol Venereol 23 2009 368
83. C.K. Hong, M.H. Lee, K.H. Jeong, C.I. Cha, and S.G. Yeo Clinical analysis of hearing levels in vitiligo patients Eur J Dermatol 19 2009 50 56
84. K.V. Gopal, G.R. Rama Rao, Y.H. Kumar, M.V. Appa Rao, and P. Vasudev Vitiligo: a part of a systemic autoimmune process Indian J Dermatol Venereol Leprol 73 2007 162 165 (Pubitemid 46918509)
85. G.E. Flynn Bilateral uveitis, poliosis, and vitiligo; with an hereditary factor Am J Ophthalmol 35 1952 568 572
86. D.M. Albert, J.J. Nordlund, and A.B. Lerner Ocular abnormalities occurring with vitiligo Ophthalmology 86 1979 1145 1160 (Pubitemid 10218606)
87. D.M. Albert, A.J. Sober, and T.B. Fitzpatrick Iritis in patients with cutaneous melanoma and vitiligo Arch Ophthalmol 96 1978 2081 2084 (Pubitemid 8404097)
88. C.L. Cowan Jr., R.M. Halder, P.E. Grimes, S.G. Chakrabarti, and J.A. Kenney Jr. Ocular disturbances in vitiligo J Am Acad Dermatol 15 1986 17 24 (Pubitemid 16090892)
89. J.J. Nordlund, and A.B. Lerner Vitiligo and melanoma Arch Dermatol 115 1979 636 (Pubitemid 9189376)
90. J.C. Bystryn, D. Rigel, R.J. Friedman, and A. Kopf Prognostic significance of hypopigmentation in malignant melanoma Arch Dermatol 123 1987 1053 1055 (Pubitemid 17134848)
91. G.O. Alabi, Z.F. Falope, and U.G. Lekwauwa Coexisting malignant melanoma and vitiligo in a Nigerian West Afr J Med 10 1991 443 446
92. K.U. Schallreuter, C. Levenig, and J. Berger Vitiligo and cutaneous melanoma. A case study Dermatologica 183 1991 239 245
93. C.L. Hexsel, M.J. Eide, C.C. Johnson, R. Krajenta, G. Jacobsen, and I. Hamzavi Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo J Am Acad Dermatol 60 2009 929 933
94. S.L. Seo, and I.H. Kim Squamous cell carcinoma in a patient with generalized vitiligo J Am Acad Dermatol 45 2001 S227 S229
95. P. Ahonen, S. Myllarniemi, I. Sipila, and J. Perheentupa Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients N Engl J Med 322 1990 1829 1836 (Pubitemid 20200407)
96. R.A. Spritz, K. Gowan, D.C. Bennett, and P.R. Fain Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis Am J Hum Genet 74 2004 188 191 (Pubitemid 38085251)
97. M.G. Butler, M.E. Hodes, P.M. Conneally, A.A. Biegel, and J.C. Wright Linkage analysis in a large kindred with autosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome) Am J Med Genet 18 1984 61 65 (Pubitemid 14148343)
98. D. Tsuruta, T. Hamada, H. Teramae, H. Mito, and M. Ishii Inflammatory vitiligo in Vogt-Koyanagi-Harada disease J Am Acad Dermatol 44 2001 129 131 (Pubitemid 32110577)
99. S.S. Wong, S.K. Ng, and H.M. Lee Vogt-Koyanagi-Harada disease: extensive vitiligo with prodromal generalized erythroderma Dermatology 198 1999 65 68 (Pubitemid 29086338)
100. L. Barnes Vitiligo and the Vogt-Koyanagi-Harada syndrome Dermatol Clin 6 1988 229 239
101. S. Sukavatcharin, J.H. Tsai, and N.A. Rao Vogt-Koyanagi-Harada disease in Hispanic patients Int Ophthalmol 27 2007 143 148 (Pubitemid 46909254)
102. N. Tesavibul, and W. Sansanayuth Vogt-Koyanagi-Harada disease in Thai patients J Med Assoc Thai 88 suppl 9 2005 S26 S30
103. S.R. Rathinam, P. Vijayalakshmi, P. Namperumalsamy, R.A. Nozik, and E.T. Cunningham Jr. Vogt-Koyanagi-Harada syndrome in children Ocul Immunol Inflamm 6 1998 155 161 (Pubitemid 28472834)
104. N. Boutimzine, A. Laghmari, I. Ouazzani, W. Ibrahimy, and Z. Mohcine Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases [in French] J Fr Ophtalmol 21 1998 746 754 (Pubitemid 29068499)
105. J.E. Ming, K.L. Russell, D.M. McDonald-McGinn, and E.H. Zackai Autoimmune disorders in Kabuki syndrome Am J Med Genet A 132A 2005 260 262 (Pubitemid 40076226)
106. A. Ewart-Toland, G.M. Enns, V.A. Cox, G.C. Mohan, P. Rosenthal, and M. Golabi Severe congenital anomalies requiring transplantation in children with Kabuki syndrome Am J Med Genet 80 1998 362 367 (Pubitemid 28541600)
107. J. McGaughran, S. Aftimos, C. Jefferies, and I. Winship Clinical phenotypes of nine cases of Kabuki syndrome from New Zealand Clin Dysmorphol 10 2001 257 262 (Pubitemid 32948314)
108. M.D. Hoffman, and C. Dudley Suspected Alezzandrini's syndrome in a diabetic patient with unilateral retinal detachment and ipsilateral vitiligo and poliosis J Am Acad Dermatol 26 1992 496 497
109. S.L. Karvonen, K.M. Haapasaari, M. Kallioinen, A. Oikarinen, I.E. Hassinen, and K. Majamaa Increased prevalence of vitiligo, but no evidence of premature ageing, in the skin of patients with bp 3243 mutation in mitochondrial DNA in the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS) Br J Dermatol 140 1999 634 639 (Pubitemid 29191380)
110. L.F. Montes, J. Abulafia, W.H. Wilborn, B.M. Hyde, and C.M. Montes Value of histopathology in vitiligo Int J Dermatol 42 2003 57 61 (Pubitemid 41709820)
111. C.L. Kovarik, R.L. Spielvogel, and G.R. Kantor Pigmentary disorders of the skin D.E. Elder, Lever's histopathology of the skin 2009 Lippincott, Williams, and Wilkins Philadelphia, PA 689 699
112. J. Bhawan Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections Melanoma Res 7 1997 43 48 (Pubitemid 27110281)
113. B.B. Gokhale, and L.N. Mehta Histopathology of vitiliginous skin Int J Dermatol 22 1983 477 480 (Pubitemid 13009601)
114. R. Kitamura, K. Tsukamoto, K. Harada, A. Shimizu, S. Shimada, and T. Kobayashi Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M J Pathol 202 2004 463 475 (Pubitemid 38456165)
115. T.S. Anbar, H. Abdel-Raouf, S.S. Awad, M.H. Ragaie, and A.T. Abdel-Rahman The hair follicle melanocytes in vitiligo in relation to disease duration J Eur Acad Dermatol Venereol 23 2009 934 939
116. I.C. Le Poole, P.K. Das, R.M. van den Wijngaard, J.D. Bos, and W. Westerhof Review of the etiopathomechanism of vitiligo: a convergence theory Exp Dermatol 2 1993 145 153 (Pubitemid 24009468)
117. S.K. Nath, P.P. Majumder, and J.J. Nordlund Genetic epidemiologyof vitiligo: multilocus recessivity cross-validated Am J Hum Genet 55 1994 981 990
118. P.A. Majumder Genetics and prevalence of vitiligo vulgaris S.K. Hann, J. Nordlund, Vitiligo: a monograph on the basic and clinical science 2000 Blackwell Science Ltd Oxford
119. X. Sun, A. Xu, X. Wei, J. Ouyang, L. Lu, and M. Chen Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China Int J Dermatol 45 2006 1176 1181 (Pubitemid 44560366)
120. X.J. Zhang, J.B. Liu, J.P. Gui, M. Li, Q.G. Xiong, and H.B. Wu Characteristics of genetic epidemiology and genetic models for vitiligo J Am Acad Dermatol 51 2004 383 390 (Pubitemid 39178665)
121. X.J. Zhang, J.J. Chen, and J.B. Liu The genetic concept of vitiligo J Dermatol Sci 39 2005 137 146
122. J.B. Liu, M. Li, H. Chen, S.Q. Zhong, S. Yang, and W.D. Du Association of vitiligo with HLA-A2: a meta-analysis J Eur Acad Dermatol Venereol 21 2007 205 213 (Pubitemid 46128696)
123. R.A. Spritz The genetics of generalized vitiligo Curr Dir Autoimmun 10 2008 244 257
124. S.A. Birlea, G.S. Laberge, L.M. Procopciuc, P.R. Fain, and R.A. Spritz CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data Pigment Cell Melanoma Res 22 2009 230 234
125. I. Canton, S. Akhtar, N.G. Gavalas, D.J. Gawkrodger, A. Blomhoff, and P.F. Watson A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo Genes Immun 6 2005 584 587 (Pubitemid 41637665)
126. H. Onay, M. Pehlivan, S. Alper, F. Ozkinay, and S. Pehlivan Might there be a link between mannose binding lectin and vitiligo? Eur J Dermatol 17 2007 146 148 (Pubitemid 46456765)
127. Y. Jin, C.M. Mailloux, K. Gowan, S.L. Riccardi, G. LaBerge, and D.C. Bennett NALP1 in vitiligo-associated multiple autoimmune disease N Engl J Med 356 2007 1216 1225 (Pubitemid 46465597)
128. Y. Ren, S. Yang, S. Xu, M. Gao, W. Huang, and T. Gao Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo PLoS Genet 5 2009 e1000523
129. A. Alkhateeb, G.L. Stetler, W. Old, J. Talbert, C. Uhlhorn, and M. Taylor Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2 Human Mol Genet 11 2002 661 667 (Pubitemid 34285137)
130. P.R. Fain, K. Gowan, G.S. LaBerge, A. Alkhateeb, G.L. Stetler, and J. Talbert A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci Am J Hum Genet 72 2003 1560 1564 (Pubitemid 36628395)
131. Y. Jin, S.L. Riccardi, K. Gowan, P.R. Fain, and R.A. Spritz Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1) J Invest Dermatol 130 2010 774 783
132. J.J. Nordlund, J.M. Kirkwood, B.M. Forget, G. Milton, D.M. Albert, and A.B. Lerner Vitiligo in patients with metastatic melanoma: a good prognostic sign J Am Acad Dermatol 9 1983 689 696 (Pubitemid 14230566)
133. A. Alajlan, A. Alfadley, and K.T. Pedersen Transfer of vitiligo after allogeneic bone marrow transplantation J Am Acad Dermatol 46 2002 606 610
134. W.Y. Au, C.K. Yeung, H.H. Chan, and A.K. Lie Generalized vitiligo after lymphocyte infusion for relapsed leukaemia Br J Dermatol 145 2001 1015 1017 (Pubitemid 34204481)
135. P. Neumeister, D. Strunk, U. Apfelbeck, H. Sill, and W. Linkesch Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma Lancet 355 2000 1334 1335 (Pubitemid 30199010)
136. F. Aubin, J.Y. Cahn, C. Ferrand, R. Angonin, P. Humbert, and P. Tiberghien Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase Lancet 355 2000 626 627 (Pubitemid 30099475)
137. S.L. Pardue, K.V. Fite, L. Bengston, S.J. Lamont, M.L. Boyle 3rd, and J.R. Smyth Jr. Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration J Invest Dermatol 88 1987 758 761 (Pubitemid 17077750)
138. S.J. Lamont, and J.R. Smyth Jr. Effect of bursectomy on development of a spontaneous postnatal amelanosis Clin Immunol Immunopathol 21 1981 407 411 (Pubitemid 12168478)
139. J.C. Bystryn Serum antibodies in vitiligo patients Clin Dermatol 7 1989 136 145
140. J. Cui, R. Harning, M. Henn, and J.C. Bystryn Identification of pigment cell antigens defined by vitiligo antibodies J Invest Dermatol 98 1992 162 165
141. J. Cui, Y. Arita, and J.C. Bystryn Characterization of vitiligo antigens Pigment Cell Res 8 1995 53 59
142. D.A. Norris, L. Capin, J.J. Muglia, R.L. Osborn, G.O. Zerbe, and J.C. Bystryn Enhanced susceptibility of melanoctyes to different immunologic effector mechanisms in vitro: potential mechanisms for postinflammatory hypopigmentation and vitiligo Pigment Cell Melanoma Res 1 1988 113 123
143. Y.H. Song, E. Connor, Y. Li, B. Zorovich, P. Balducci, and N. Maclaren The role of tyrosinase in autoimmune vitiligo Lancet 344 1994 1049 1052 (Pubitemid 24310036)
144. E. Baharav, O. Merimski, Y. Shoenfeld, R. Zigelman, B. Gilbrud, and G. Yecheskel Tyrosinase as an autoantigen in patients with vitiligo Clin Exp Immunol 105 1996 84 88 (Pubitemid 26231829)
145. Z. Xie, D. Chen, D. Jiao, and J.C. Bystryn Vitiligo antibodies are not directed to tyrosinase Arch Dermatol 135 1999 417 422 (Pubitemid 29172093)
146. T. Okamoto, R.F. Irie, S. Fujii, S.K. Huang, A.J. Nizze, and D.L. Morton Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy J Invest Dermatol 111 1998 1034 1039 (Pubitemid 29115171)
147. E.H. Kemp, D.J. Gawkrodger, P.F. Watson, and A.P. Weetman Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2) Clin Exp Immunol 109 1997 495 500 (Pubitemid 27402319)
148. E.H. Kemp, E.A. Waterman, D.J. Gawkrodger, P.F. Watson, and A.P. Weetman Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay Br J Dermatol 139 1998 798 805 (Pubitemid 28520285)
149. H. Hedstrand, O. Ekwall, M.J. Olsson, E. Landgren, E.H. Kemp, and A.P. Weetman The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I J Biol Chem 276 2001 35390 35395
150. J. Cui, Y. Arita, and J.C. Bystryn Cytolytic antibodies to melanocytes in vitiligo J Invest Dermatol 100 1993 812 815 (Pubitemid 23151245)
151. G.K. Naughton, D. Reggiardo, and J.C. Bystryn Correlation between vitiligo antibodies and extent of depigmentation in vitiligo J Am Acad Dermatol 15 1986 978 981 (Pubitemid 17176811)
152. R. Harning, J. Cui, and J.C. Bystryn Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo J Invest Dermatol 97 1991 1078 1080
153. D.A. Norris, R.M. Kissinger, G.M. Naughton, and J.C. Bystryn Evidence for immunologic mechanisms in human vitiligo: patients's sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity J Invest Dermatol 90 1988 783 789
154. A. Gilhar, B. Zelickson, Y. Ulman, and A. Etzioni In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo J Invest Dermatol 105 1995 683 686
155. K. Ongenae, N. Van Geel, and J.M. Naeyaert Evidence for an autoimmune pathogenesis of vitiligo Pigment Cell Res 16 2003 90 100 (Pubitemid 36596954)
156. S.K. Hann, Y.K. Park, K.G. Lee, E.H. Choi, and S. Im Epidermal changes in active vitiligo J Dermatol 19 1992 217 222
157. I.C. Le Poole, R.M. van den Wijngaard, W. Westerhof, and P.K. Das Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance Am J Pathol 148 1996 1219 1228 (Pubitemid 26108257)
158. A.M. Badri, P.M. Todd, J.J. Garioch, J.E. Gudgeon, D.G. Stewart, and R.B. Goudie An immunohistological study of cutaneous lymphocytes in vitiligo J Pathol 170 1993 149 155 (Pubitemid 23192367)
159. G.S. Ogg, P. Rod Dunbar, P. Romero, J.L. Chen, and V. Cerundolo High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo J Exp Med 188 1998 1203 1208 (Pubitemid 28443344)
160. B. Palermo, R. Campanelli, S. Garbelli, S. Mantovani, E. Lantelme, and V. Brazzelli Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo J Invest Dermatol 117 2001 326 332 (Pubitemid 34205718)
161. K.S. Lang, C.C. Caroli, A. Muhm, D. Wernet, A. Moris, and B. Schittek HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1 J Invest Dermatol 116 2001 891 897 (Pubitemid 32554374)
162. J.C. Becker, P. Guldberg, J. Zeuthen, E.B. Brocker, and P.T. Straten Accumulation of identical T cells in melanoma and vitiligo-like leukoderma J Invest Dermatol 113 1999 1033 1038 (Pubitemid 30013349)
163. E. Jager, M. Maeurer, H. Hohn, J. Karbach, D. Jager, and Z. Zidianakis Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides Int J Cancer 86 2000 538 547 (Pubitemid 30249736)
164. G.E. Orecchia Neural pathogenesis S. Hann, J. Nordlund, Vitiligo 2000 Blackwell Science Ltd Oxford
165. M.S. Al'sAbadie, H.J. Senior, S.S. Bleehen, and D.J. Gawkrodger Neuropeptide and neuronal marker studies in vitiligo Br J Dermatol 131 1994 160 165 (Pubitemid 24251486)
166. K.U. Schallreuter, J.M. Wood, M.R. Pittelkow, G. Buttner, N. Swanson, and C. Korner Increased monoamine oxidase A activity in the epidermis of patients with vitiligo Arch Dermatol Res 288 1996 14 18 (Pubitemid 26009220)
167. B. Iyengar Modulation of melanocytic activity by acetylcholine Acta Anat 136 1989 139 141 (Pubitemid 19263771)
168. A. Morrone, M. Picardo, C. de Luca, O. Terminali, S. Passi, and F. Ippolito Catecholamines and vitiligo Pigment Cell Res 5 1992 65 69
169. S.G. Durneva Changes in the content of epinephrine and norepinephrine in the blood of patients with vitiligo [in Russian] Vestn Dermatol Venerol 47 1973 33 36
170. B.A. Salzer, and K.U. Schallreuter Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism Dermatology 190 1995 109 115
171. G. Orecchia, P. Frattini, M.L. Cucchi, and G. Santagostino Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report Dermatology 189 1994 350 353 (Pubitemid 24357984)
172. K.U. Schallreuter, J.M. Wood, I. Ziegler, K.R. Lemke, M.R. Pittelkow, and N.J. Lindsey Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo Biochim Biophys Acta 1226 1994 181 192 (Pubitemid 24182463)
173. I.C. Le Poole, R.M. van den Wijngaard, N.P. Smit, J. Oosting, W. Westerhof, and S. Pavel Catechol-O-methyltransferase in vitiligo Arch Dermatol Res 286 1994 81 86 (Pubitemid 24025573)
174. S.K. Hann, and W. Chun autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo S.K. Hann, J. Nordlund, Vitiligo 2000 Blackwell Science Ltd Oxford
175. K.U. Schallreuter, J.M. Wood, M.R. Pittelkow, M. Gutlich, K.R. Lemke, and W. Rodl Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin Science 263 1994 1444 1446 (Pubitemid 24137834)
176. K.U. Schallreuter, G. Buttner, M.R. Pittelkow, J.M. Wood, N.N. Swanson, and C. Korner Cytotoxicity of 6-biopterin to human melanocytes Biochem Biophys Res Commun 204 1994 43 48 (Pubitemid 24335259)
177. K.U. Schallreuter, J.M. Wood, and J. Berger Low catalase levels in the epidermis of patients with vitiligo J Invest Dermatol 97 1991 1081 1085
178. K.U. Schallreuter, J. Moore, J.M. Wood, W.D. Beazley, D.C. Gaze, and D.J. Tobin In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase J Investig Dermatol Symp Proc 4 1999 91 96 (Pubitemid 29491263)
179. C.B. Casp, J.X. She, and W.T. McCormack Genetic association of the catalase gene (CAT) with vitiligo susceptibility Pigment Cell Res 15 2002 62 66 (Pubitemid 34535975)
180. S. Aronoff Catalase: kinetics of photooxidation Science 150 1965 72 73
181. W.D. Beazley, D. Gaze, A. Panske, E. Panzig, and K.U. Schallreuter Serum selenium levels and blood glutathione peroxidase activities in vitiligo Br J Dermatol 141 1999 301 303 (Pubitemid 29398000)
182. K.U. Schallreuter-Wood, M.R. Pittelkow, and N.N. Swanson Defective calcium transport in vitiliginous melanocytes Arch Dermatol Res 288 1996 11 13 (Pubitemid 26009219)
183. Y. Gauthier, M. Cario Andre, and A. Taieb A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16 2003 322 332 (Pubitemid 36950564)
184. Y. Gauthier, M. Cario-Andre, S. Lepreux, C. Pain, and A. Taieb Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo Br J Dermatol 148 2003 95 101 (Pubitemid 36114868)
185. I.C. Le Poole, R.M. van den Wijngaard, W. Westerhof, and P.K. Das Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion Br J Dermatol 137 1997 171 178 (Pubitemid 27333347)
186. A.Y. Lee, N.H. Kim, W.I. Choi, and Y.H. Youm Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo J Invest Dermatol 124 2005 976 983
187. G.M. Dunston, and R.M. Halder Vitiligo is associated with HLA-DR4 in black patients. A preliminary report Arch Dermatol 126 1990 56 60 (Pubitemid 20040982)
188. M. Arcos-Burgos, E. Parodi, M. Salgar, E. Bedoya, J. Builes, and D. Jaramillo Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA Hum Genet 110 2002 334 342 (Pubitemid 36067460)
189. P.R. Fain, S.R. Babu, D.C. Bennett, and R.A. Spritz HLA class II haplotype DRB104-DQB10301 contributes to risk of familial generalized vitiligo and early disease onset Pigment Cell Res 19 2006 51 57
190. L.M. Foley, N.J. Lowe, E. Misheloff, and J.L. Tiwari Association of HLA-DR4 with vitiligo J Am Acad Dermatol 8 1983 39 40 (Pubitemid 13221136)
191. M. Zamani, M. Spaepen, S.S. Sghar, C. Huang, W. Westerhof, and L. Nieuweboer-Krobotova Linkage and association of HLA class II genes with vitiligo in a Dutch population Br J Dermatol 145 2001 90 94 (Pubitemid 32862792)
192. H.C. de Vijlder, W. Westerhof, G.M. Schreuder, P. de Lange, and F.H. Claas Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study Pigment Cell Res 17 2004 270 274 (Pubitemid 38724557)
193. G.T. Venneker, L.P. de Waal, W. Westerhof, J. D'sAmaro, G.M. Schreuder, and S.S. Asghar HLA associations in vitiligo patients in the Dutch population Dis Markers 11 1993 187 190 (Pubitemid 24010027)
194. J. Wang, Y.M. Zhao, Y. Wang, Y. Xiao, Y.K. Wang, and H.D. Chen Association of HLA class I and II alleles with generalized vitiligo in Chinese Hans in north China [in Chinese] Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24 2007 221 223 (Pubitemid 46624804)
195. X.J. Zhang, H.S. Liu, Y.H. Liang, L.D. Sun, J.Y. Wang, and S. Yang Association of HLA class I alleles with vitiligo in Chinese Hans J Dermatol Sci 35 2004 165 168 (Pubitemid 38969042)
196. S. Yang, J.Y. Wang, M. Gao, H.S. Liu, L.D. Sun, and P.P. He Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans Int J Dermatol 44 2005 1022 1027 (Pubitemid 43046121)
197. Q. Xia, W.M. Zhou, Y.H. Liang, H.S. Ge, H.S. Liu, and J.Y. Wang MHC haplotypic association in Chinese Han patients with vitiligo J Eur Acad Dermatol Venereol 20 2006 941 946
198. A. Poloy, L. Tibor, J. Kramer, N. Anh-Tuan, E. Kraszits, and I. Medgyessy HLA-DR1 is associated with vitiligo Immunol Lett 27 1991 59 62
199. I. Ando, H.I. Chi, H. Nakagawa, and F. Otsuka Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type Br J Dermatol 129 1993 408 410 (Pubitemid 23308244)
200. A. Metzker, R. Zamir, E. Gazit, M. David, and E.J. Feuerman Vitiligo and the HLA system Dermatologica 160 1980 100 105 (Pubitemid 10192945)
201. A. al-Fouzan, M. al-Arbash, F. Fouad, S.A. Kaaba, M.A. Mousa, and S.A. al-Harbi Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients Eur J Immunogenet 22 1995 209 213
202. R. Orozco-Topete, J. Cordova-Lopez, J.K. Yamamoto-Furusho, V. Garcia-Benitez, A. Lopez-Martinez, and J. Granados HLA-DRB1 04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease J Am Acad Dermatol 52 2005 182 183 (Pubitemid 40038976)
203. G. Orecchia, L. Perfetti, P. Malagoli, F. Borghini, and Y. Kipervarg Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients Dermatology 185 1992 123 127
204. K.U. Schallreuter, C. Levenig, P. Kuhnl, C. Loliger, M. Hohl-Tehari, and J. Berger Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany Dermatology 187 1993 186 192 (Pubitemid 23267298)
205. M.N. Venkataram, A.G. White, W.A. Leeny, A.R. al Suwaid, and A.S. Daar HLA antigens in Omani patients with vitiligo Clin Exp Dermatol 20 1995 35 37
206. A. Abanmi, F. Al Harthi, R. Al Baqami, S. Al Assaf, A. Zouman, and M. Arfin Association of HLA loci alleles and antigens in Saudi patients with vitiligo Arch Dermatol Res 298 2006 347 352
207. M. Buc, B. Busova, E. Hegyi, and K. Kolibasova Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations Folia Biol (Krakow) 42 1996 23 25 (Pubitemid 26108485)
208. M. Buc, H. Fazekasova, E. Cechova, E. Hegyi, K. Kolibasova, and S. Ferencik Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo Eur J Dermatol 8 1998 13 15 (Pubitemid 28264142)
209. H.B. Tastan, A. Akar, F.E. Orkunoglu, E. Arca, and A. Inal Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population Pigment Cell Res 17 2004 181 184 (Pubitemid 38419646)
210. I.C. Le Poole, R. Sarangarajan, Y. Zhao, L.S. Stennett, T.L. Brown, and P. Sheth VIT1's, a novel gene associated with vitiligo Pigment Cell Res 14 2001 475 484 (Pubitemid 34010075)
211. R.K. Tripathi, D.J. Flanders, T.L. Young, W.S. Oetting, A. Ramaiah, and R.A. King Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation Pigment Cell Res 12 1999 187 192 (Pubitemid 129686280)
212. C.B. Casp, J.X. She, and W.T. McCormack Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo Genes Immun 4 2003 492 499 (Pubitemid 38967616)
213. S.Y. Jin, H.H. Park, G.Z. Li, H.J. Lee, M.S. Hong, and H.J. Park Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients J Dermatol Sci 35 2004 181 186 (Pubitemid 39295692)
214. S. Birlea, M. Birlea, D. Cimponeriu, P. Apostol, R. Cosgarea, and L. Gavrila Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community Acta Derm Venereol 86 2006 209 214 (Pubitemid 43875204)
215. K. Kingo, M.A. Philips, E. Aunin, H. Luuk, M. Karelson, and R. Ratsep MYG1, novel melanocyte related gene, has elevated expression in vitiligo J Dermatol Sci 44 2006 119 122 (Pubitemid 44499008)
216. R. de la Fuente-Fernandez Mutations in GTP-cyclohydrolase I gene and vitiligo Lancet 350 1997 640
217. D. Bandyopadhyay, E. Lawrence, P.P. Majumder, and R.E. Ferrell Vitiligo is not caused by mutations in GTP-cyclohydrolase I gene Clin Exp Dermatol 25 2000 152 153 (Pubitemid 30212427)
218. R. Tazi-Ahnini, A.J. McDonagh, D.A. Wengraf, T.R. Lovewell, Y. Vasilopoulos, and A.G. Messenger The autoimmune regulator gene (AIRE) is strongly associated with vitiligo Br J Dermatol 159 2008 591 596